UHealth - University of Miami Health System

Reshma L. Mahtani, DO

Información general

Reshma L. Mahtani, DO



  • English
  • Hindi


  • American Board of Internal Med-Medical Oncology
  • American Board of Internal Medicine
  • American Board of Internal Med-Hematology



  • Internal Medicine
  • Hematology/Oncology - Internal Medicine


  • Assistant Professor of Clinical Medicine

Intereses clínicas

Breast Cancer


2004-2007 Fellowship
St. Vincent's Catholic Medical Center: New York, NY
2002-2004 Residency
St. Vincent's Catholic Medical Center: New York, NY
2001-2002 Internship
Greenwich Hospital: Greenwich, CT
2001 Medical School
University of New England: Biddleford, ME


  • Miller K, Diéras V, Harbeck N, Andre F, Mahtani R, Gianni L, Albain K, Crivellari D, Liang F, Michelson G, Burris H. Phase IIa Trial of Trastuzumab Emtansine (T-DM1) With Pertuzumab for Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer. Journal of Clinical Oncology (vol 32) 1437-1445, 2014
  • Savas J, Mahtani R. Skin Diseases in the Immunocompromised, Chapter 8: Cutaneous Complications of Chemotherapy. Edited by John C. Hall (in press)
  • Modi S, Saura C, Henderson C, Lin NU, Mahtani R, Goddard J, Rodenas E, Hudis C, O'Shaughnessy J, Baselga J. A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer. Breast Cancer Res Treat. 2013 Apr 12.
  • Vogel C, Mahtani R. Patterns of Care: Breast Cancer in the 21st Century. Managed Care Pathways 1 (vol2) 18-22, 2012
  • Vogel C, Mahtani R. Evolution of Targeted Therapies for Breast Cancer in the 21st Century. Managed Care Pathways 1 (vol2) 23-26, 2012
  • Ambros T, Zeichner S, Zaravinos J, Montero A , Ahn E, Mani A, Kronish L, Mahtani R, Vogel C. Low-dose capecitabine monotherapy in HER-2 negative metastatic breast cancer: a retrospective study. Cancer Research: December 15, 2012; Volume 72, Issue 24, Supplement 3
  • Sandoval J, Mahtani R, Gluck S. HER2-positive metastatic breast cancer: a double-edged sword. Breast Cancer Management Vol 1, No. 3, 181-184, 2012
  • Mahtani R, Khan R., Jahanzeb, M. The Potential Application of Zolendronic Acid as Anticancer Therapy in Patients with Non-Small Cell Lung Cancer. Clinical Lung Cancer Vol 12, No 1, 26-32, 2011.
  • Mahtani R, Jahanzeb, M. Bisphosphonates as Anticancer Therapy for Early Breast Cancer, Clinical Breast Cancer Vol. 10, No. 5, 359-366, 2010
  • Vogel C, Mahtani R. Associate Guest Editors, Clinical Therapeutics, Volume 31, Part2, 2009
  • Mahtani R. Vogel, C. High-Dose Estrogen as Salvage Hormonal Therapy for Highly Refractory Metastatic Breast Cancer: A Retrospective Chart Review. Clinical Therapeutics, Volume 31, Part 2, Theme Issue 2009: 2371-2378
  • Mahtani R. Managing Care in the Cervical Cancer Patient. Managed Care Oncology, Quarter 2 2009: 15-22.
  • Mahtani R. Screening, Diagnosis and Treatment Considerations for Ovarian Cancer. Managed Care Oncology, Quarter 4, 2008: 13-16
  • Mahtani R., Vogel C. Three Pleomorphic Lobular Carcinomas of the Breast - Long Term Responders to Herceptin. Coincidence or a Hint? Journal of Clinical Oncology –(Correspondence) Dec 10, 2008: 5823-5824
  • Mahtani R, Macdonald J. Mechanisms of Synergy for Cetuximab and Chemotherapy in Tumors of the Gastrointestinal Tract. The Oncologist, 2008. Vol 13(1): 39-47.
  • Gurvits G, Mahtani R, Halperin I. Hepatitis C virus and splenic marginal zone lymphoma with villous lymphocytes: Away from conventional therapy. Scandanavian Journal of Gastroenterology, 2007. Volume 42(11); 1392-1393.
  • Mahtani R, Waltzman R, Macdonald J. Gastric Cancer: Adjuvant Therapy. In: Macdonald, J., ed. Advances in the Management of Gastric Cancer. New York. CMPMedica, 2006:35-53.
  • Lillaney R, Maher T, Chaiyuakul R, and Ally A. Changes in extracellular glutamate and pressor response during muscle contraction following AMPA-receptor blockage in the RVLM and CVLM. Brain Research 844(1999) 164-173
  • Freda B, Gaitonde R, Lillaney R, and Ally A. Cardiovascular responses to muscle contraction following microdialysis of nitric oxide precursor into ventrolateral medulla. Brain Research 828(1999) 60-67
  • Deckel W, Lillaney R, Ronan P, Summers C. Lateralized effects of ethanol on aggression and serotonergic systems in Anolis carolinensis. Brain Research 807(1998) 38-46


Reshma Mahtani, DO is a board certified hematologist and medical oncologist. She is an assistant professor of Clinical Medicine for the division of Hematology/Oncology at the University of Miami Miller School of Medicine. Dr. Mahtani served as Sylvester Comprehensive Cancer Center’s principal investigator on several phase II and III breast clinical trials. Her clinical interests include breast and GYN malignancies. She has authored numerous manuscripts related to breast, GYN, gastrointestinal cancer, and lung cancer. She is a member of the Breast Cancer Core Committee for ECOG, and is the Medical Director for the Best of ASCO Philadelphia. Dr. Mahtani has spoken nationally and internationally on breast cancer.

E-mail a Friend